Plasma serotonin level in left-sided colonic diverticulosis: A pilot study

• Authors: Katarzyna Neubauer , Małgorzata Krzystek-Korpacka , Leszek Paradowski
• Languages of publication: EN

Abstracts

EN

Neurotransmitters might participate in the development of diverticular disease. We measured fasting and postprandial serotonin levels in colonic diverticulosis patients and healthy volunteers. We demonstrated significantly lower maximal concentrations of serotonin in patients than the controls (respectively 109.8±61.4 and 251.3±44.1 ng/ml, p<0.001) as well as lower serotonin minimal values (respectively 38.4±21.8 and 124.6±41.4 ng/ml, p<0.001) and areas under time-course curves (respectively 288.8±139.8 and 739±167.4 ng/ml, p<0.001); significant difference between alternating pattern and normal bowel habit concerning fasting serotonin level, the hormone response to test meal (p=0.041) as well as minimal serotonin level (p=0.044). Bowel habit was also related to peak serotonin values following a test meal with 38.5 ng/ml in constipation, 139.5 ng/ml in diarrhea, 122.4 ng/ml in alternating pattern and 249 ng/ml in subjects with normal bowel habit (p=0.040) as well as AUC with 120.8 ng/ml in constipation, 416 ng/ml in diarrhea, 298 ng/ml in alternating pattern and 684 ng/ml in subjects with normal bowel habit (p=0.043). We demonstrated substantial differences in fasting serum serotonin levels as well as the hormone response to a test meal between colonic diverticulosis patients and healthy individuals, which seemed to be associated with abnormal bowel habits rather than presence of diverticula.

Keywords

EN

Serotonin; Diverticulosis; Colon

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2012
• Volume: 7
• Issue: 5
• Pages: 591-595

Dates

published

1 - 10 - 2012

online

28 - 7 - 2012

Contributors

author

Katarzyna Neubauer

• Department of Gastroenterology and Hepatology, Wroclaw Medical University, Borowska 213, 50-556, Wroclaw, Poland

author

Małgorzata Krzystek-Korpacka

• Department of Medical Biochemistry, Wroclaw Medical University, Chalubinskiego 10, 50-368, Wroclaw, Poland

author

Leszek Paradowski

• Department of Gastroenterology and Hepatology, Wroclaw Medical University, Borowska 213, 50-556, Wroclaw, Poland

References

• [1] Neubauer K., Dudkowiak R., Paradowski L., Leftsided diverticulosis of the large bowel as the second most common abnormality in colonoscopy - review of 425 cases of colonic diverticulosis, Adv. Clin. Exp. Med., 2010, 19, 513–518
• [2] Nguyen G.C., Sam J., Anand N., Epidemiological trends and geographic variation in hospital admissions for diverticulitis in the United States, World J. Gastroenterol., 2011, 17, 1600–1605 http://dx.doi.org/10.3748/wjg.v17.i12.1600[WoS][Crossref]
• [3] Jeyarajah S., Faiz O., Bottle A., Aylin P., Bjarnason I., Tekkis P.P., et al., Diverticular disease hospital admissions are increasing, with poor outcomes in the elderly and emergency admissions, Aliment. Pharmacol. Ther., 2009, 30, 1171–1182 http://dx.doi.org/10.1111/j.1365-2036.2009.04098.x[Crossref][WoS]
• [4] Jeyarajah S., Papagrigoriadis S., Review article: the pathogenesis of diverticular disease - current perspectives on motility and neurotransmitters, Aliment. Pharmacol. Ther., 2011, 33, 789–800 http://dx.doi.org/10.1111/j.1365-2036.2011.04586.x[Crossref][WoS]
• [5] Sikander A., Rana S.V., Prasad K.K., Role of serotonin in gastrointestinal motility and irritable bowel syndrome, Clin. Chim. Acta., 2009, 403, 47–55 http://dx.doi.org/10.1016/j.cca.2009.01.028[Crossref][WoS]
• [6] Banerjee S., Akbar N., Moorhead J., Rennie J.A., Leather A.J., Cooper D., Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition, Int. J. Colorectal. Dis., 2007, 6, 643–649 http://dx.doi.org/10.1007/s00384-006-0216-4[Crossref][WoS]
• [7] Costedio M.M., Coates M.D., Danielson A.B., Buttolph T.R. 3rd, Blaszyk H.J., Mawe G.M., et al., Serotonin signaling in diverticular disease, J. Gastrointest. Surg., 2008, 12, 1439–1445 http://dx.doi.org/10.1007/s11605-008-0536-5[Crossref][WoS]
• [8] Spiller R., Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease, Neurogastroenterol. Motil., 2007, 19(Suppl. 2), 25–31 http://dx.doi.org/10.1111/j.1365-2982.2007.00965.x[WoS][Crossref]
• [9] Tan K.Y, Seow-Chowen F., Fiber and colorectal diseases: separating fact from fiction, World J. Gastroenterol., 2007, 13, 4161–4167
• [10] Spiller R.C.L., Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome, Curr. Opin. Pharmacol., 2011, 11, 68–74 http://dx.doi.org/10.1016/j.coph.2011.02.005[Crossref]
• [11] Ford A.C., Brandt L.J., Young C., Chey W.D., Foxx-Orenstein A.E., Moayyedi P., Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis, Am. J. Gastroenterol., 2009, 104, 1831–1843 http://dx.doi.org/10.1038/ajg.2009.223[Crossref]
• [12] Tursi A., Diverticular disease: a therapeutic overview, World J. Gastrointest. Pharmacol. Ther., 2010, 1, 27–35 http://dx.doi.org/10.4292/wjgpt.v1.i1.27[Crossref]
• [13] Dunlop S.P., Coleman N.S., Blackshow E., Perkins A.C., Singh G., Mardsen C.A., Spiller R.C., Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome, Clin. Gastroenterol. Hepatol., 2005, 3, 349–357 http://dx.doi.org/10.1016/S1542-3565(04)00726-8[Crossref]
• [14] Atkinson W., Lockhart S., Whorwell P.J., Keevil B., Houghton L.A., Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome, Gastroenterology, 2006, 130, 34–43 http://dx.doi.org/10.1053/j.gastro.2005.09.031[Crossref]
• [15] Bearcroft C.P., Perrett D., Farthing M.J.G., Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study, Gut, 1998, 42, 42–46 http://dx.doi.org/10.1136/gut.42.1.42[Crossref]

Identifiers

DOI

10.2478/s11536-012-0041-9